Jaguar Health, Inc.

Jaguar Health, Inc., formerly Jaguar Animal Health, Inc., incorporated on June 6, 2013, is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc., is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Its Mytesi is an antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with human immunodeficiency virus HIV/ acquired immune deficiency syndrome (AIDS) on antiretroviral therapy.

Bank Name Jaguar Health, Inc.
Stock Exchange NASDAQ
Symbol JAGX
Sector Healthcare
Industry Major Pharmaceuticals
Country United States
World Region Amarica
CEO Ms. Lisa A. Conte
Employees 36
Registered Year